Biocon Ltd. — Major Shareholding Notification 2018

Sep 11, 2018

Biocon Limited

20th KM Hosur Road Electronics City Bangalore 560 100, lndia T 91 80 2808 2808 CIN : L24234KA1978PLC003417

Date of submission: September 11, 2018 F 91 80 2852 3423

'To	To
VThe SecretaryV	www.blocon.comThe Secretary
Listing Department	Listing Department
BSE Limited	National Stock Exchangeof India Limited
Department 'of CorporateServices	Exchange Plaza, Bandra Kurla Complex
Phiroze JeejeebhoyTowers,	Mumbai —400 050
Dalal Street, Mumbai —400 001	Scrip Code- BIOCON
Scrip Code -532523

Dear Sir/Madam,

Sub: Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 and Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015.

Pursuant to Regulation 29(2) ofthe SEBI (Substantial Acquisition ofShares and Takeover) Regulations, 2011 and Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015, we wish to inform you that Biocon Limited ("the Promoter") along with the Person Acting in Concert (PAC); Biocon Research Limited, (forming part of the Promoter Group) has decreased the shareholding in Syngene International Limited, subsidiary of the Company by ~0.50 % of total holdings pursuant to sale of shares in the open market on September 11 2018, details as under.

SL.NO	SELLER	NO. OF SHARESHELD	NO.OFSHARESSOLD	% OF SALE	DATE OF SALE
1	Biocon Limited	14,13,08,942	8,21,556'	0.41%	September 11 2018
2	BioconResearchLimited	1,78,444	1,78,444	0.09%	September 11 2018

Please find enclosed the form in respect of the said disclosure.

We request you to kindly take this to your record as per the requirement of Listing Regulations and oblige.

Thanking You, Yours faithfully For Biocon Limited

(got/65v" [Cm/Mm 5,Q

A

Satish Kumar SS Company Secretary and Compliance Officer Encl: As above

Disclosures under Regulation 29(2) of SEBI

(Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Name ofthe TargetCompany (TC)	Syngene International Limited
Name(s) ofthe Acquirerand Persons Actinginwith the acquirerConcert (PAC)	Biocon Limited & Biocon Research Limited
Whether the acquirerbelongs toPromoter/Promoter group	Promoter Group
ofthe Stock Exchange(s)whereNa me(s)the shares of TCare Listed	of IndiaBSE Limited and National Stock ExchangeLimited
Details ofthe disposalare as follows	Number	% w.r.t.totalshare/votingcapitalwhereverapplicable(*)	% w.r.t.totaldilutedshare/votingcapital ofthe TC(**)
Before thesale under
ofconsideration, holding:	(***)
a) Shares carryingvoting rights	14,14,87,386	70.74%	70.74%
b) Shares in the nature of encumbrance	NIL	NlL	NlL
(pledge/ Iien/ non-disposalundertaking/others)
c) Voting rights (VR) otherwise than by	NIL	NIL	NIL
shares
d) Warra nts/convertiblesecurities/any other
instrument that entitlesthe acquirerto	NIL	NIL	NlL
receive shares carryingvoting rights in the
holding in each category)TC (specify
e) Total (a+b+c+d)	14,14,87,386	70.74%	70.74%
Details ofsale
a) Shares carryingvoting rights
aequired/sold	10,00,000	0.50%	0.50%
/so d otherwise than byb) VRs acquired	NIL
shares		NIL	NIL
securities/any otherc) Wa rrants/convertible
instrument that entitles theacquirer to	NIL
receive shares carryingvoting rights in the		NIL	NIL
holding in each category)TC (specify
acquired/sold	NIL
d) Shares encumbered /invoked/released		NIL	NIL
by the acquirer

(QM/L Kw"r"

	e) Total (a+b+c+d)	10,00,000	0.50%	0.50%
	sale,' holding of:After'the
	a) Shares carryingvoting rights	14,04,87,386	70.24%	70.24%
	b) Shares encumbered with the acquirer	NIL	NIL	NIL
	c) VRs otherwise than byshares
	securities/any otherd) Warra nts/convertible	NIL	NIL	NIL
	instrument that entitles the acquirerto
	voting rights in the TCreceive shares carrying	NIL	NIL	NIL
	(specify, holding in
	after acquisitioneach category)
	e) Total (a+b+c+d)	14,04,87,386	70.24%	70.24%
6.	Mode ofsale	Open Market
7.	Date ofsale of shares	September 11, 2018
	Itotalvoting capital ofEquity share capital	20,00,00,000
	the TCbefore the said sale
	I total votingcapital ofEquity share capital	20,00,00,000
	the TC after thesaid sale
10'	capital ofTotal diluted share/votingthe TC	20,00,00,000'
	after the said sale

• (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Regulation 31 of SEBl Listing Obligations and Disclosure Requirements.
• (**)Di|uted share/voting capital means the total number of shares in the TC assuming full conversion 'ofthe outstanding convertible securities/warra nts into equity shares of the TC. ~

(***) Both Biocon Limited and Biocon Research Limited before the sale on September 11, 2018

Thanking You, Yours faithfully For'Biocon Limited

(gmKIM/Wot SS

Satish Kumar 55 Company Secretary and Compliance Officer Encl: As above

CC

To, Syngene International Ltd, Biocon Park , SEZ, Bommasandra Industrial Area - Phase-IV Bommasandra-Jigani Link Road, Bangalore 560 099 India